Live
- They always want me to win, and now I feel lucky to have been offered a story like ‘Zebra’: Satyadev Kancharana
- ‘Democracy first, humanity first’: PM Modi in Guyana's parliament on two countries' similarities
- PKL Season 11: Telugu Titans register third straight win to top standings
- Is Pollution Contributing to Your COPD?
- NASA Unveils Underwater Robots for Exploring Jupiter's Moons
- Additional Central forces arrive in violence-hit Manipur
- AR Rahman and Saira Banu’s Divorce: Legal Insights into Common Issues in Bollywood Marriages
- 82.7 pc work completed in HPCL Rajasthan Refinery area: official
- Curfew relaxation extended in 5 Manipur districts on Friday
- Tab scam prompts Bengal govt to adopt caution over fund disbursement
Serum working on vaccine for Mpox
New Delhi: Serum Institute of India on Tuesday said it is currently working to develop a vaccine for monkeypox, with positive outcomes expected in a...
New Delhi: Serum Institute of India on Tuesday said it is currently working to develop a vaccine for monkeypox, with positive outcomes expected in a year's time. The World Health Organisation on August 14 declared the Mpox outbreak a public health emergency of international concern.
The move came after a sudden increase in cases was recorded in parts of Africa.
In India, around 30 Mpox cases have been detected since 2022. The most recent case in the country was reported in March 2024.
"In view of the global health emergency declared due to Mpox outbreak, Serum Institute of India is currently working on developing a vaccine for this disease to cater to millions of lives that might be at risk," Serum Institute of India CEO Adar Poonawalla said in a statement.
Hopefully, with the ongoing progress, the Pune-based vaccine major will have more updates and positive news to share within a year's time, he added.
